ATE303810T1 - In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe - Google Patents

In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe

Info

Publication number
ATE303810T1
ATE303810T1 AT00915730T AT00915730T ATE303810T1 AT E303810 T1 ATE303810 T1 AT E303810T1 AT 00915730 T AT00915730 T AT 00915730T AT 00915730 T AT00915730 T AT 00915730T AT E303810 T1 ATE303810 T1 AT E303810T1
Authority
AT
Austria
Prior art keywords
dyes
vivo
methods
dysplastic tissue
identifying
Prior art date
Application number
AT00915730T
Other languages
English (en)
Inventor
Douglas D Burkett
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Application granted granted Critical
Publication of ATE303810T1 publication Critical patent/ATE303810T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/006Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/20[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36[b, e]-condensed, at least one with a further condensed benzene ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Sanitary Thin Papers (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT00915730T 2000-01-31 2000-01-31 In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe ATE303810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/002602 WO2001054696A1 (en) 2000-01-31 2000-01-31 In vivo stain compounds and methods of use to identify dysplastic tissue

Publications (1)

Publication Number Publication Date
ATE303810T1 true ATE303810T1 (de) 2005-09-15

Family

ID=21741026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915730T ATE303810T1 (de) 2000-01-31 2000-01-31 In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe

Country Status (23)

Country Link
US (1) US6830743B1 (de)
EP (1) EP1165087B1 (de)
JP (1) JP2003520816A (de)
KR (1) KR100641972B1 (de)
CN (1) CN1219515C (de)
AT (1) ATE303810T1 (de)
AU (1) AU784639B2 (de)
BR (1) BR0009427A (de)
CA (1) CA2366759A1 (de)
CZ (1) CZ20013504A3 (de)
DE (1) DE60022487T2 (de)
DK (1) DK1165087T3 (de)
EA (1) EA003939B1 (de)
ES (1) ES2248061T3 (de)
HU (1) HUP0201634A3 (de)
IL (1) IL145589A0 (de)
MX (1) MXPA01009797A (de)
NO (1) NO322012B1 (de)
PL (1) PL349999A1 (de)
SK (1) SK13782001A3 (de)
TR (1) TR200102815T1 (de)
TW (1) TWI250157B (de)
WO (1) WO2001054696A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462346B2 (en) * 2001-08-28 2008-12-09 Zila Biotechnology, Inc. Light-stabilized(in vivo) stain composition and method of manufacture
US20050089472A1 (en) * 2003-10-22 2005-04-28 Shovers Aaron H. Monitoring the status of a condition of an animal through visually observable indicia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
JPS63187154A (ja) * 1987-01-29 1988-08-02 Kishida Kagaku Kk 酸素検知剤
ES2133143T3 (es) * 1991-10-31 1999-09-01 Zila Inc Composicion de tincion biologica, procedimiento de preparacion y procedimiento de utilizacion para la deteccion del cancer epitelial.
US5942410A (en) * 1997-07-07 1999-08-24 Oncometrics Imaging Corp. Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol
US6417003B1 (en) * 1993-01-14 2002-07-09 Zila, Inc. Method and kit for epithelial cancer screening
EP0814847B1 (de) * 1996-01-16 2003-11-05 Zila, Inc. Verfahren und mittel zur in-vivo erkennung von mundhöhlenkrebs und von präkanzerösen zuständen
CA2249227A1 (en) * 1997-01-20 1998-07-23 Kyowa Medex Co., Ltd. Methods and reagents for quantitatively determining ascorbic acid
DE19716586C1 (de) * 1997-04-21 1998-08-06 Continental Ag Verfahren zum Ermitteln der Profiltiefe eines Fahrzeugreifens am fahrenden Fahrzeug
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
US6649144B1 (en) * 2000-02-28 2003-11-18 Zila, Inc. Method for detecting and killing epithelial cancer cells

Also Published As

Publication number Publication date
EP1165087B1 (de) 2005-09-07
CN1345241A (zh) 2002-04-17
EP1165087A1 (de) 2002-01-02
JP2003520816A (ja) 2003-07-08
ES2248061T3 (es) 2006-03-16
EP1165087A4 (de) 2003-04-02
AU784639B2 (en) 2006-05-18
DE60022487T2 (de) 2006-07-13
KR100641972B1 (ko) 2006-11-02
EA200101028A1 (ru) 2002-02-28
US6830743B1 (en) 2004-12-14
TR200102815T1 (tr) 2002-05-21
CA2366759A1 (en) 2001-08-02
AU3695600A (en) 2001-08-07
HUP0201634A2 (en) 2002-09-28
DK1165087T3 (da) 2005-11-21
EA003939B1 (ru) 2003-10-30
NO20014720L (no) 2001-11-27
WO2001054696A1 (en) 2001-08-02
KR20010108431A (ko) 2001-12-07
NO322012B1 (no) 2006-08-07
CN1219515C (zh) 2005-09-21
HUP0201634A3 (en) 2009-08-28
TWI250157B (en) 2006-03-01
DE60022487D1 (de) 2005-10-13
NO20014720D0 (no) 2001-09-28
SK13782001A3 (sk) 2002-02-05
BR0009427A (pt) 2002-07-16
IL145589A0 (en) 2002-06-30
CZ20013504A3 (cs) 2002-04-17
MXPA01009797A (es) 2002-11-04
PL349999A1 (en) 2002-10-21

Similar Documents

Publication Publication Date Title
DE59912963D1 (de) Medizinisches instrument zum präparieren von gewebe
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE69920178D1 (de) Super-elastische gebogene hohlnadel zur medizinischen verwendung
DE50011194D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
DE60238898D1 (de) Oxidative Zusammensetzung zur Behandlung von Keratinfasern, die spezielle Aminosilikone enthält
DE60211106D1 (de) Zusammensetzung zur Oxidationsfärbung von Keratinfasern
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
DE60021903D1 (de) Verwendung von zusammensetzungen zur textilpflege
DE60207288D1 (de) Gewebespezifische fluoreszierende chelate
DE50105185D1 (de) Verfahren zur Herstellung von Dithiazolyldisulfiden
DE60128640D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Halo-3-Hydroxybutanoat
ATE303810T1 (de) In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe
DE60031108D1 (de) Verfahren zur Herstellung von Vinylamin-Vinylalkohol-Copolymeren und Verwendung davon
DE50109698D1 (de) N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate
DK0948967T3 (da) Behandling af virussygdom hos svin
ATE525356T1 (de) 2,5-diaminopyridin oxidationsbasen, deren verwendung zur färbung von keratinischen fasern
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60208365D1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
MXPA03006424A (es) Novedosos derivados de 1,4-diamino-2-alquenil-benceno y colorantes que contienen dichos compuestos.
DE69903610D1 (de) Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz
FR2838337B1 (fr) Composition pour la teinture d'oxydation des fibres keratiniques humaines
DE50108671D1 (de) Semikontinuierliches verfahren zur herstellung von 4,4'-dihydroxydiphenylsulfon
DE60011870D1 (de) Verfahren zur Herstellung von 4'-Isobutylacetophenon
DE60336275D1 (de) Verfahren zur Herstellung von 3-(1,3-Dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als Dopamin-beta-hydroxylase Inhibitor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165087

Country of ref document: EP

REN Ceased due to non-payment of the annual fee